WT-1 regulates the oncogenicity of leukemia cells by activating JAK/STAT3 and MAPK signaling [17, 18], therefore we explored the role of JAK/STAT3 and MAPK signaling in the WT1-mediated resistance to DOX. Here, STAT3 is linked to leukemia.